Abdo Abou-Slaybi
Impact in
- Internal Medicine top 10%
- Venous Thromboembolism Diagnosis and Management
- Hematology top 10%
- Platelet Disorders and Treatments
Papers in
- Oncology 3
- Inflammatory Biomarkers in Disease Prognosis 2
- CAR-T cell therapy research 1
-
- Angiogenesis and VEGF in Cancer 2
- Co-authors
- Judah Folkman (2 shared papers)Nava Almog (2 shared papers)Joseph E. Italiano (2 shared papers)Giannoula Klement (2 shared papers)Vladimir N. Podust (2 shared papers)David Cervi (2 shared papers)Tai‐Tung Yip (2 shared papers)Elise R. Bender (2 shared papers)
- Journals
- Blood (2 papers)Progress in Retinal and Eye Research (1 paper)Investigative Ophthalmology & Visual Science (1 paper)The Journal of Immunology (1 paper)Cancer Research (1 paper)
- Partner nations
- United States
In The Last Decade
Abdo Abou-Slaybi
6 papers receiving 410 citations
Peers
Comparison fields: 5 of 64
- Internal Medicine 49
- Hematology 138
- Oncology 181
- Cancer Research 84
- Immunology and Allergy 21
Countries citing papers authored by Abdo Abou-Slaybi
This map shows the geographic impact of Abdo Abou-Slaybi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Abdo Abou-Slaybi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Abdo Abou-Slaybi more than expected).
Fields of papers citing papers by Abdo Abou-Slaybi
This network shows the impact of papers produced by Abdo Abou-Slaybi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Abdo Abou-Slaybi. The network helps show where Abdo Abou-Slaybi may publish in the future.
Co-authors
The 25 scholars most cited alongside Abdo Abou-Slaybi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2008 | 261 | |
| 2 | 2007 | 120 | |
| 3 | 2020 | 39 | |
| 4 | Plasmacytoid Dendritic Cells Inhibit Vascular Endothelial Cell Proliferation and Differentiation through the Angiostatic Molecule Platelet Factor-4 | 2019 | 1 |
| 5 | 2019 | 1 | |
| 6 | 2021 | 1 |
About Abdo Abou-Slaybi
Abdo Abou-Slaybi is a scholar working on Oncology, Molecular Biology, Public Health, Environmental and Occupational Health, Radiology, Nuclear Medicine and Imaging and Hematology, having authored 6 papers that have together received 423 indexed citations. Recurring topics across this work include Ocular Surface and Contact Lens (2 papers), Angiogenesis and VEGF in Cancer (2 papers), Platelet Disorders and Treatments (2 papers), Inflammatory Biomarkers in Disease Prognosis (2 papers), Immunotherapy and Immune Responses (2 papers), Atherosclerosis and Cardiovascular Diseases (1 paper), Corneal Surgery and Treatments (1 paper) and CAR-T cell therapy research (1 paper). The work is most often cited by research in Internal Medicine (49 citations), Hematology (138 citations), Oncology (181 citations), Cancer Research (84 citations) and Immunology and Allergy (21 citations). Abdo Abou-Slaybi has collaborated with scholars based in United States. Frequent co-authors include Judah Folkman, Nava Almog, Joseph E. Italiano, Giannoula Klement, Vladimir N. Podust, David Cervi, Tai‐Tung Yip, Elise R. Bender, Flávia Cassiola and Mark W. Kieran. Their work appears in journals such as Blood, Progress in Retinal and Eye Research, Investigative Ophthalmology & Visual Science, The Journal of Immunology and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.